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Abstract
The construction of a library of benzothiaoxazepine-1,1’-dioxides utilizing a one-pot, SNAr
diversification – ODCT50 scavenging protocol is reported. This protocol combines microwave
irradiation to facilitate the reaction, in conjunction with a soluble ROMP-derived scavenger
(ODCT) to afford the desired products in good overall purity. Utilizing this protocol, a 78-member
library was successfully synthesized and submitted for biological evaluation.
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1. Introduction
Advances in high-throughput screening and the need for new pharmaceutical leads have led
to the emergence of methods and technologies to access diverse collections of small
molecules. This has led to advances of synthetic platforms such as flow-through, micro-
reactors, microwave, immobilized reagents/scavengers and advances in methodology
including new efficient synthetic protocols, multi-component reactions, parallel synthesis
and green chemistry. To this effect, a variety of high-load, soluble immobilized reagents
derived from ring-opening metathesis polymerization (ROMP) has emerged. These
oligomeric reagents and scavengers have been efficiently utilized in facilitated protocols for
the generation of S- and P-heterocycles.1
Alongside platform innovation, the advancement of multi-component cascade protocols to
rapidly access core scaffolds in multi-gram quantities is of high importance. Cascade or
domino reactions are highly efficient pathways that allow for the synthesis of complex
molecules from simple substrates and encompass a variety of transformations.2 With such
scaffolds in hand, the utilization of facilitated purification-free protocols utilizing
immobilized reagents and scavengers, has become a useful method to rapidly access small
molecule libraries. In this regard, we herein report the synthesis of a library of
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benzothiaoxazepine-1,1’-dioxides via a one-pot, SNAr diversification protocol utilizing a
ODCT50 scavenger.
Sultams (cyclic sulfonamide analogues) have emerged in recent years as important targets in
drug discovery due to their extensive chemical and biological profiles.3 Though not found in
nature, a number of benzofused sultams have recently appeared in the literature, which
display potent activity across a variety of biological targets. Such reports include, inhibition
of a variety of enzymes, including HIV integrase,4 COX-2 (Ampiroxicam),5,6 HCV NS5b
RNA-dependent RNA-polymerase,7 cysteine proteases involved in the progression of
malaria8 and lipoxygenases.9 In particular, benzoxazepine-1,1-dioxides have exhibited a
wide array of biological activity, including: (1) histone deacetylase inhibition (for treatment
of cognitive disorders such as Alzheimers desease),10 (2) glucokinase activation,11 (3)
serotonin 5-HT2C activation,12 (4) modulation of the histamine H3 receptor,13 (5) inhibition
of MDM2-p53,14 (6) inhibition of sodium-proton exchange, (7) bradykinin B1 receptor
antagonism (for treating Alzheimer’s disease),15 (8) AMPA receptor agonism,16 and (9)
inhibition of metalloproteinase.17
2. Results and Discussion
We recently reported the development and application of a one-pot cascade protocol for the
synthesis of benzothiaoxazepine-1,1’-dioxides and oxathiazepine-1,1’-dioxides.18 With this
method in hand, we envisioned its utilization in the synthesis of a library of
benzothiaoxazepine-1,1’-dioxides where-by diversification could be incorporated via SNAr
reaction at the aromatic fluoride position with a variety of nucleophiles (Scheme 1).
To this effect, a variety of benzothiaoxazepine-1,1’-dioxide scaffolds 1-9 were synthesized
possessing fluorine substitution at the 6-position with varying functionality at the R1 and R2
positions (Scheme 2, Table 1).
With these scaffolds in hand, diversification of the aryl fluoride position utilizing an SNAr
reaction with isopropylphenol {6} was performed on scaffold 1 (Scheme 3, Table 2).
Initially, reactions were conducted using conventional thermal heating, followed by
screening of a variety of bases, solvent and phenol equivalents to yield the desired product
in high conversion (Table 2, entry 1-10). It was found that utilizing 3 equivalents of phenol
{6} in the presence of Cs2CO3 and DMSO gave the desired product in >95% conversion
after heating at 110 °C for 8 hours (Table 2, entry 10). Further optimization of the reaction
conditions was investigated with the aim of reducing reaction times via the implementation
of microwave irradiation (Table 2, entry 11-13). It was found that reaction times could be
reduced to 30 minutes (Table 2, entry 12), while maintaining conversion at >95%.
Despite isolating the desired product 1{6} in high yield, the utilization of 3 equivalent’s of
phenol {6} was undesirable for parallel synthesis. When utilizing amines as the nucleophilic
species, simple silica SPE was employed efficiently to remove excess amine. However,
phenols cannot be removed by simple silica SPE and the application of aqueous work-up
would require the utilization of a robotic platform. Therefore, it was envisioned that the
unreacted nucleophile (phenol, thiophenol, amine and sulfonamide) could be scavenged
utilizing the previously reported high load, soluble scavenger derived from ring-opening
metathesis polymerization (ROMP).19 In this regard, the utilization of oligomeric
dichlorotriazine (ODCT50) was investigated for the removal of excess phenol {6} from the
crude reaction mixture (Scheme 4).
Utilizing previously published conditions as a starting point,19 scavenging of the crude
reaction mixture utilizing 3 equivalents of 2GODCT50 at 110 °C (thermal heating), yielded
the desired crude product in >90% purity by 1H NMR [Table 3, entry 1-3]. Despite these
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results, having to scavenge crude reactions for 10 h in a parallel format was not an optimal
protocol for library production. Therefore, we investigated a two-step sequential procedure
could be carried out under microwave irradiation to yield the desire product in high yield
and purity without the need of conventional purification techniques. The utilization
of 2GODCT50 under microwave irradiation was investigated (Table 3, entry 4-9) and it was
found that reaction conditions could be reduced to 30 minutes at 50 °C with final crude
purity >95% (Table 3, entry 8).20 Overall, a reaction carried out thermally requiring 8 hours
of reaction time and 10 hours of scavenging (18 h/reaction) has been reduced to 30 minutes
of reaction time and 30 min of scavenging (1 h/reaction) by the utilization of microwave
irradiation.
With these optimized procedures in hand, a prototype library was investigated on scaffolds 1
and 7 utilizing a variety of phenols. In addition, a number of amines and sulfonamides were
included to probe their potential application as nucleophilic species in the SNAr
diversification (Scheme 5, Table 4).
The successful synthesis of the 16-membered prototype library yielded an average crude
purity of 70%, final yield of 59.5 % and an average final purity of 98.3 % after automated
preparative reverse phase HPLC. Taking these results in hand, we proposed the synthesis of
a 72-membered library (Scheme 6), with the remaining scaffolds 1 – 9 and the
corresponding nucleophilic species {1-21} (Figure 3).
In comparison to the prototype library, crude purity was on average lower due to the
presence of either starting material or unknown by-products. Overall, 59 of 78 members in
this library yielded the desired products in 12-82% yield with 47 in 90% purity or greater
after automated preparative reverse phase HPLC. It was found that submission of scaffolds 2
and 5 to the library reaction conditions gave poor yield and in most cases reaction failed (12
examples) due to the formation of unidentified by-products. Additionally it is proposed that
the failure of nucleophile {2} was due to unfavorable steric interactions.
Conclusion
In conclusion, we have developed an efficient protocol for the diversification of
benzothiaoxazepine-1,1’-dioxides via intermolecular diversification with a variety of
nucleophilic species. A ROMP-derived oligomeric scavenger ODCT50 was successfully
utilized to scavenge excess nucleophilic species yielding the desired compounds in good
crude purity. A total of 76 compounds were synthesized utilizing this protocol and




All air and moisture sensitive reactions were carried out in flame- or oven-dried glassware
under argon atmosphere using standard gas tight syringes, cannula, and septa. Stirring was
achieved with oven-dried, magnetic stir bars. CH2Cl2 was purified by passage through the
Solv-Tek purification system employing activated Al2O3 (Grubbs, R. H.; Rosen, R. K.;
Timmers, F. J. Organometallics 1996, 15, 1518-1520). Et3N was purified by passage over
basic alumina and stored over KOH. Flash column chromatography was performed with
SiO2 from Sorbent Technology (30930M-25, Silica Gel 60A, 40-63 um). Thin layer
chromatography was performed on silica gel 60F254 plates (EM-5717, Merck). Deuterated
solvents were purchased from Cambridge Isotope laboratories. 1H and 13C NMR spectra
were recorded on a Bruker Avance operating at 500 MHz and 126 MHz respectively. High-
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resolution mass spectrometry (HRMS) and FAB spectra were obtained in one of two
manners: (i) on a VG Instrument ZAB double-focusing mass spectrometer and (ii) on a LCT
Premier Spectrometer (Micromass UK Limited) operating on ESI (MeOH). All library
syntheses was carried out in 1 dram vials utilizing Anton Parr ® Synthon 3000 microwave
platform. Parallel evaporations were performed using a GeneVac EZ-2 plus evaporator.
Automated preparative reverse-phase HPLC purification was performed using an Agilent
1200 Mass-Directed Fractionation system (Prep Pump G1361 w/ gradient extension, Make-
up pump G1311A, pH modification pump G1311A, HTS PAL autosampler, UV-DAD
detection G1315D, Fraction Collector G1364B, and Agilent 6120 quadrapole spectrometer
G6120A). The preparative chromatography conditions included a Waters X-Bridge C18
column (19 × 150mm, 5um, w/ 19 × 10mm guard column), elution with a water and CH3CN
gradient which increases 20% in CH3CN content over 4 minutes at a flow rate of 20 mL/min
(modified to pH 9.8 through addition of NH4OH by using an auxiliary pump), and sample
dilution in DMSO. The preparative gradient, triggering thresholds, and UV wavelength were
selected based on the HPLC analysis of each crude sample. The analytical method employed
an Agilent 1200 RRLC system with UV detection (Agilent 1200 DAD SL) and mass
detection (Agilent 6224 TOF). The analytical method conditions included a Waters Aquity
BEH C18 column (2.1 × 50mm, 1.7μm) and elution with a linear gradient of 5% CH3CN in
pH 9.8 buffered aqueous NH4HCO3 to 100% CH3CN at 0.4 mL/min flow rate. The purity
was determined using UV peak area at 214nm.
General procedure A for the synthesis of Benzothiaoxazepine-1,1’-dioxide scaffolds 1-9
Into a microwave vial (0.5-2.0 mL) was added 2,6-difluorobenzene sulfonamide (2 mmol),
anhydrous Cs2CO3 (6 mmol), BnEt3NCl (0.2 mmol), epoxide (2 mmol) and dry dioxane/
DMF (1:1, 1M). The microwave vial was heated at 110 °C for 20 minutes, after such time
the reaction was purified (directly loading of crude reaction mixture) by flash
chromatography (8:2 hexane/EtOAc) to afford the desired sultam.
General procedure B for the synthesis of library members
Into a 1-dram vial was added Cs2CO3 (0.17g, 0.54 mmol, 3 eq.), a stock solution of
corresponding sultam (0.136 mmol) in dry DMSO (70 μL) [Stock solution A] and
nucleophile (0.40 mmol, 3 eq.). The reaction was heated in microwave at 110 °C for 30 min,
followed by cooling to RT. To the crude reaction mixture was added a stock solution of
ODCT50 (70 mg) in dry CH2Cl2 (1 mL), and the crude reaction mixture was heated at 60 °C
for an additional 30 min in the microwave. After such time the crude reaction mixture was
diluted (hexane:EtOAc, 1 mL) and filtered through a silica SPE, flushing with solvent
(hexane:EtOAc, 5 mL). The resulting organic filtrate was concentrated and analyzed by
HPLC (UV 214 nm). Crude material with purity below 90% was submitted to purification
by mass-directed fractionation (MDF).
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Phenols, amines and sulfonamide nucleophiles for library synthesis.
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One-pot epoxide cascade protocol library plan.
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Synthesis of core benzothiaoxazepine-1,1’-dioxide scaffolds 1-9b.
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Optimization of SNAr of phenol {6} on scaffold 1.
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Optimization and utilization of ODCT as an efficient scavenger of phenol {6}.
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Synthesis of the corresponding prototype library from scaffold 1 and 7.
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Proposed 72-membered library of Benzothiaoxazepine-1,1’-dioxides.
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Table 1
Synthesis of benzothiaoxazepine-1,1’-dioxide scaffolds via epoxide cascade protocol.
entry R1 R2 Yield (%)
1 butyl CH2OBn 1 (73 %)
2 propargyl CH2O(CH2)2CH3 2 (69 %)
3 (R)-1-phenylethyl (S)-CH2OBn 3 (76 %)
4 cyclopropane (S)-CH2OBn 4 (84 %)
5 propargyl CH2OPh 5 (81 %)
6 4-methoxybenzyl CH2CH2CH=CH 6 (69 %)
7 butyl CH2O(CH2)2CH3 7 (79 %)
8 cyclopentyl (R)-CH2OC(O)Pr 8 (82 %)
9 4-methoxybenzyl (R)-CH2OBn 9 (89 %)
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Table 3
Optimization of scavenging protocol
entry 2GODCT50 temp. time puritya
1 1 eq. 150 °C 10 h 70%
2 3 eq. 150 °C 10 h > 90%
3 3 eq. 110 °C 10 h > 90%
4b 3 eq. 150 °C 1 h > 90%
5b 3 eq. 150 °C 30 min > 95%
6b 3 eq. 150 °C 10 min 80 %
7b 3 eq. 100 °C 30 min > 95%
8b 3 eq. 50 °C 30 min > 95%
9b 3 eq. 30 °C 30 min 80 %
a
Purity analyzed by 1H NMR spectroscopy (experimental error 5%).
b
Reactions carried out under microwave irradiation (Anton Parr 300 synthesizer)
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